Answers are grounded in this paper and cite their sources.
Artificial Intelligence (AI) can facilitate the interpretation of data obtained from biosensors and wearable devices. However, the full utility of AI in the measurement and clinical follow-up process is not yet fully realized. This narrative review will explore the applications of machine learning in conjunction with personalized monitoring and multimodal sensing in healthcare. It will cover already published studies in this field and provide examples of signal classification, detection and other opportunities while addressing blind spots in data and coverages, referencing testing and population representation. The review will cover diagnostic accuracy and the need for evidence of improved patient outcomes. The review will also cover a hypothetical example of a screening test to illustrate that in cases of sensitivity and specificity being close to 100%, large numbers of false alerts can still occur. The review aims to communicate that, for clinical utility of such systems, the follow-up and control of model updates will be necessary.
No takes yet. Share an insight, caveat, or question.
Jinxin Gao (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: